Share on LinkedInShare on LinkedIn

ARTICLE · 08 JULY 2026

Brazil Revises Its Patent Examination Guidelines For New Use Inventions: Key Changes And Remaining Challenges

Licks Attorneys
Licks Attorneys
Contributor
Licks Attorneys

Licks Attorneys

Licks Attorneys is one of Brazil’s most respected litigation law firms, having unparalleled...

View firm profile
Explore more from Licks Attorneys

Brazil's patent office has revised its examination guidelines for new use inventions in chemistry, particularly medical uses, following extensive stakeholder consultation. The updated rules now permit post-filing data under certain conditions while maintaining restrictions on dosage regimen and patient group claims, creating a mixed landscape for pharmaceutical patent protection in Latin America's largest market.

BrazilIntellectual Property

BRPTO’s Rule #208/2017 sets forth the Examination Guidelines for Patent Applications in the Field of Chemistry, specifically addressing, in Chapter 9, the criteria for evaluating new uses of known products – particularly new medical uses – in Brazil.

On June 30, 2026, the BRPTO published and enacted Ordinance #80/2026, amending Chapter 9 and concluding the public consultation process initiated almost one year earlier through Call for Contributions #02/2025.

Compared to the initial draft published under Call for Contributions #02/2025, the final and official text reflects the efforts of stakeholders, including Brazilian and International associations, to achieve more balanced requirements, demonstrating the importance of a transparent dialogue between the IP community and the BRPTO.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from